|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Tick-Borne Disease, Antibody Panel
Test Code36942
CPT Codes
86666 (x4), 86753 (x3), 86618
Includes
Anaplasma phagocytophilum Antibodies (IgG, IgM)
WA1 IgG Antibody, IFA
Babesia microti Antibodies (IgG, IgM), IFA
Lyme Disease Ab with Reflex to Blot (IgG, IgM)
Ehrlichia chaffeensis (IgG, IgM)
If Lyme Disease Antibody Screen is ≥0.90, then Lyme Disease Antibodies (IgG, IgM), Immunoblot will be performed at an additional charge (CPT code(s): 86617 x2).
WA1 IgG Antibody, IFA
Babesia microti Antibodies (IgG, IgM), IFA
Lyme Disease Ab with Reflex to Blot (IgG, IgM)
Ehrlichia chaffeensis (IgG, IgM)
If Lyme Disease Antibody Screen is ≥0.90, then Lyme Disease Antibodies (IgG, IgM), Immunoblot will be performed at an additional charge (CPT code(s): 86617 x2).
Preferred Specimen
2 mL serum
Minimum Volume
1.5 mL
Transport Container
Plastic screw-cap container
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 72 hours
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly icteric • Grossly lipemic
Methodology
See individual tests
Setup Schedule
Set up: Tues-Sat; Report available: 1-3 days
Reference Range
See individual tests
Clinical Significance
There is substantial clinical overlap among tick-borne diseases caused by Anaplasma, Babesia, Borrelia, and Ehrlichia. Some infections can progress to severe complications such as anemia, hepatitis and pneumonia.. More than one infectious agent may be transmitted by the same tick, and rates of co-infection are not well defined since clinicians may only suspect a single tick-borne disease etiology.
